Biocon Biologics refinances debt through USD bonds and syndicated term loan 0 03.10.2024 06:59 Business Standard Biocon Biologics (BBL), a subsidiary of Biocon, today announced the successful pricing of Biocon Biologics' debut USD 800 million (Rs 6676.3 crore) senior secured Notes due 2029 at a coupon of 6.67%. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
